CASE COMMENTS: MERGERS – FRENCH COMPETITION AUTHORITY – MARKET DEFINITIONS – REMEDIES

Remedies: The French Competition Authority authorizes, subject to structural and behavioral remedies, the merger between two health-care groups in the South of France (Hexagone Santé Méditerranée, Bonnefon-Carnot / ELSAN)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Reviewing a well-established decision-making practice (See in particular the letters from the Minister of the Economy: C-2007-91 to the board of Vitalia Développement 2, concerning a merger in the sector of diagnostics and care in healthcare institutions; C-2007-80 of 24 July 2007 to the board of Vitalia Développement 1, concerning a merger in the sector of healthcare institutions in France; and the decisions of the French Competition Authority: No. 18-DCC-162 of 15 October 2018 relating to the acquisition of exclusive control of the Capio group by Ramsay Générale de Santé; No. 17-DCC-95 of 23 June 2017 relating to the acquisition of exclusive control of the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

François Brunet, Céline Verney, Remedies: The French Competition Authority authorizes, subject to structural and behavioral remedies, the merger between two health-care groups in the South of France (Hexagone Santé Méditerranée, Bonnefon-Carnot / ELSAN), 28 February 2020, Concurrences N° 3-2020, Art. N° 96314, pp. 132-134

Visites 30

All reviews